jCell is a first-in-class allogeneic cell therapy in late-stage clinical development for retinitis pigmentosa. The treatment is a minimally invasive ...
People also ask
What is a jCell?
What were the results of the jCyte clinical trial?
What is the latest news about retinitis pigmentosa in 2024?
What is stem cell therapy for retinitis pigmentosa?
Feb 24, 2024 · The treatment is a minimally invasive intravitreal injection that can be performed with a topical anesthetic.
jCell is a first-in-class investigational treatment in late-stage clinical development for retinitis pigmentosa (RP), and other inherited retinal and blinding ...
7 days ago · Stem cell therapy (jcell) is under development for the treatment of Retinitis pigmentosa (RP) and other inherited retinal and blinding diseases.
Feb 24, 2024 · The treatment is a minimally invasive intravitreal injection that can be performed with a topical anesthetic.
Feb 21, 2024 · Announces Positive Pre-Phase 3 FDA Type B Meeting and Outlines Plans to Start Pivotal Trial of jCell® for Retinitis Pigmentosa in The Second ...
Feb 21, 2024 · The biotechnology company is preparing to launch a pivotal, Phase 3 clinical trial in the US for its emerging jCell therapy. The company's ...
A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa.
Jul 21, 2023 · In a phase 2b study, jCell (famzeretcel, jCyte), a product that consists of allogeneic retinal progenitor cells (RPCs), may benefit patients ...
No information is available for this page. · Learn why